Synergistic effects of N-acetylcysteine combined with common psychological of patients with cannabis use disorder

Phase 3

• Conditions: Patients with cannabis use disorder.; Cannabis abuse with intoxication; F12.12

• Registration Number: IRCT20161026030510N5
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Having the criteria for cannabis abuse based on DSM-5
Being between the ages of 18 and 30 years

Exclusion Criteria

Having a history of brain damage (epilepsy, convulsions, trauma, etc)
Having other underlying medical diseases such as neurological disorders, etc
History of severe psychiatric comorbidity (including schizophrenia, bipolar disorder, and psychotic disorders)
Concomitant use of psychiatric drugs
Concomitant use of drugs abuse other than smoking

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Craving Score in Craving questionnaire. Timepoint: Before the start of the intervention and 12 weeks after the intervention. Method of measurement: MCQ-SF: marijuana craving questionnaire-shor form.;Retention in treating. Timepoint: Weekly. Method of measurement: Urine test.;Quantitative electroencephalographic indice. Timepoint: Before the start of the intervention and 12 weeks after the intervention. Method of measurement: EEG machine.